Original Article
Prostate Cancer and Prostatic Diseases (2009) 12, 285–287; doi:10.1038/pcan.2009.22; published online 2 June 2009
Rescoring the NIH chronic prostatitis symptom index: nothing new
J Q Clemens1, E A Calhoun2, M S Litwin3, M McNaughton-Collins4, R L Dunn1, E M Crowley5 and J R Landis5 for the Urologic Pelvic Pain Collaborative Research Network6
- 1Department of Urology, University of Michigan Medical Center, Ann Arbor, MI, USA
- 2Department of Health Policy and Administration, University of Illinois at Chicago School of Public Health, Chicago, IL, USA
- 3Department of Urology, UCLA Schools of Medicine and Public Health, Los Angeles, CA, USA
- 4Department of Medicine, Harvard Medical School, Boston, MA, USA
- 5Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA
- 6National Institutes of Diabetes, Digestive and Kidney Diseases, Bethesda, MD, USA
Correspondence: Dr JQ Clemens, Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Taubman Center 3875, Ann Arbor, MI 48109-5330, USA. E-mail: qclemens@umich.edu
Received 16 April 2009; Revised 4 May 2009; Accepted 4 May 2009; Published online 2 June 2009.
Abstract
The National Institutes of Health-chronic prostatitis symptom index (NIH-CPSI) is a commonly used 13-item questionnaire for the assessment of symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). For each item, score ranges are 0–1 (6 items), 0–3 (2 items), 0–5 (3 items), 0–6 (1 item) and 0–10 (1 item). This scoring system is straightforward, but items with wider score ranges are de facto weighted more, which could adversely affect the performance characteristics of the questionnaire. We rescored the NIH-CPSI so that equal weights were assigned to each item, and compared the performance of the standard and rescored questionnaires using the original validation dataset. Both the original and revised versions of the scoring algorithm discriminated similarly among groups of men with CP (n=151), benign prostatic hyperplasia (n=149) and controls (n=134). The internal consistency of the questionnaire was slightly better with the revised scoring, but values with the standard scoring were sufficiently high (Cronbach's
0.80). We conclude that although the rescored NIH-CPSI provides better face validity than the standard scoring algorithm, it requires additional calculation efforts and yields only marginal improvements in performance.
Keywords:
chronic pelvic pain syndrome, questionnaire, psychometrics
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Traditional therapy for chronic pelvic pain does not work: what do we do now?
Nature Clinical Practice Urology Review (01 Mar 2006)
Traditional therapy for chronic pelvic pain does not work: what do we do now?
Nature Clinical Practice Urology Review (01 Mar 2006)
NEWS AND VIEWS
Prostatitis No benefit of α-blockers for chronic prostatitis
Nature Reviews Urology News and Views (01 Apr 2009)
Prostatitis Clinical phenotyping of patients with pelvic pain
Nature Reviews Urology News and Views (01 Oct 2009)
RESEARCH
Prostate Cancer and Prostatic Diseases Original Article
